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ABSTRACT
IMPLICATIONS OF PGRMC1 REGULATION OF KIT LIGAND SYNTHESIS IN
THE HIPPOCAMPUS
SEPTEMBER 2017
HALEY WOODS
B.S., UNIVERSITY OF NEW HAMPSHIRE
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Sandra L. Petersen
The mammalian hippocampus is responsible for many crucial brain functions such as
learning, memory, and neurogenesis in adults. Its degeneration is a pathology associated
with the early stages of Alzheimer’s disease. A variety of genes have been associated
with both neuroprotection and neurogenesis in the brain, some of which include
progesterone membrane component 1 (Pgrmc1) and kit ligand (KitL). Pgrmc1 is
recognized for mediating hormonal functions in both the ovary and neuroendocrine
regions such as the anteroventral periventricular nucleus (AVPV), but its functions in the
hippocampus are not well known. Both Pgrmc1 and KitL share downstream targets, the
most strongly supported being genes in the Janus kinase (Jak)/signal transducer and
activator of transcription (Stat) pathway. I hypothesized that Pgrmc1 regulates neural
targets through KitL/c-Kit signaling. To investigate this hypothesis I used a variety of in
vivo and in vitro techniques. These techniques included mapping both KitL and receptor
c-Kit in the adult female rat brain using in situ hybridization. I used Pgrmc1 silencing
iii

with siRNA in hippocampal-derived mHe-18 cells and Pgrmc1/2 double conditional
knock out mouse brains to study Pgrmc1 regulation of KitL synthesis. To determine
common downstream targets of KitL and Pgrmc1 I then treated mHe-18 cells with
soluble KitL protein. Finally, to determine whether c-Kit mediated effects of Pgrmc1, I
treated cells with both Pgrmc1 siRNA and AG-1296, a c-Kit inhibitor. The results show
that Pgrmc1 regulates KitL expression, as well as downstream targets Pias1, 2, 3, and 4.
However, AG-1296 did not abrogate Pgrmc1 regulation of the downstream targets,
demonstrating regulation independent of KitL signaling. Taken together, these results
suggest that while Pgrmc1 alters KitL expression and regulates the same genes as KitL/cKit, the mechanism of action likely differs. Considering that these two genes are involved
in neurogenesis and neuroprotection, as well as memory and learning, a better
understanding of the pathways may help lead the way in treating neurodegenerative
diseases in the future.
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CHAPTER 1
INTRODUCTION
1.1 Pgrmc1
Progesterone receptor membrane component 1 and 2 (Pgrmc1 and Pgrmc2) are
part of a larger group of molecules that function in nonclassical progesterone (P4)
signaling (Petersen, 2013). Pgrmc1 has one transmembrane domain and an extracellular
binding site that is believed to bind hemes, sterols, and progestogens (Cahill & Medlock,
2016). Pgrmc1 can interact with both Pgrmc2 and plasminogen activator inhibitor RNAbinding protein 1 (PAIRBP1), but also self-dimerizes (Peluso, 2008). Though the ability
of Pgrmc1 to directly bind P4 has been widely debated, there are many examples of
Pgrmc1 mediating P4 effects. In spontaneously immortalized granulosa cells (SIGCs),
Pgrmc1 levels directly relate to sensitivity of P4 anti-apoptotic effects shown in cell
viability assays (Peluso, et al., 2006). Studies done with partially purified liver
membranes containing Pgrmc1 have shown P4 binding with Kd estimates of 11nM
(Meyer, et al. 1996).
Though Pgrmc1 is shown to mediate P4-dependent effects, it has other functions
that are P4-independent, such as heme-binding and membrane trafficking (Cahill, et al.,
2016). Recent findings regarding the structure of Pgrmc1 suggest that the membrane
trafficking function may be regulated by phosphorylation of Pgrmc1 at position Y113
(Cahill, et al., 2016). Unfortunately, sub-cellular localization is not yet fully understood
and Pgrmc1 has been found to localize in many places. Pgrmc1 has been found in the
nucleus of SIGCs (Peluso, et al., 2008), the cell membrane of spinal cord neurons
(Labombarda, et al., 2003), and the organellar membranes of the endoplasmic reticulum
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and Golgi apparatus in Purkinje cells (Sakamotoa, et al., 2004). It has also been
confirmed that Pgrmc1 can localize to the nucleus and act as a transcription factor
(Peluso, 2012). The diverse localization of Pgrmc1 supports the notion that it can
function in a variety of manners from being a P4 receptor to entering the nucleus as a
transcription factor.
1.2 The role of Pgrmc1 in neuroprotection and neurogenesis
Work by Intlekofer and Petersen (Petersen, 2013) detected Pgrmc1 and Pgrmc2 in
the hypothalamus and hippocampus, as well as other areas linked to P4-regulated
functions. Pgrmc1 has been shown to mediate neuroprotective effects of P4 following
spinal cord injury or traumatic brain injury, linking it to functions of neuroprotection
(Guennoun, et al. 2008). In the hippocampus, neurogenesis fluctuates over the course of
the estrous cycle and this response can be recapitulated with different doses of estradiol
(E2) and P4, this is thought to be regulated by Pgrmc1 (Bali, et al., 2012). Moreover,
Pgrmc1 was recently shown to reduce cognitive deficits and neuroinflammation in animal
models of Alzheimer’s (Yi, et al. 2016).
It is not yet clear how Pgrmc1 might regulate neurogenesis or hippocampal
functions, but we previously identified kit ligand (kitl; also known as stem cell factor;
Adams and Petersen, unpublished) as a target of Pgrmc1. KitL encodes a cytokine that
seems to share a variety of functions with Pgrmc1.
1.3 The role of Kit Ligand in neuroprotection and neurogenesis
KitL is a growth factor and cytokine that is found in membrane-bound and soluble
forms, both of which interact with the KitL tyrosine kinase receptor, c-Kit (Lennartsson
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and Rönnstrand 2012). In the brain, KitL signaling has been tied to neural
stem/progenitor cell (NSPC) migration from the subgranular zone (SGZ) to the dentate
gyrus of the hippocampus, as well as migration to damaged neuronal areas where cell
death has occurred (Sun, Lee and Fine 2004). Mice with a mutation in the tyrosine
kinase domain of the c-Kit receptor show poor performance in the Morris water maze
when compared to the wild type (Katafuchi, et al. 2000), suggesting a role in spatial
learning and memory functions controlled by the hippocampus. Like Pgrmc1, KitL is also
connected to neuroprotection as induction of kit ligand expression can be seen in brain
cells within the vicinity of brain injury brought on by a lack of blood flow and oxygen
(Sun, Lee and Fine 2004). It has also been suggested that KitL promotes neurogenesis
and formation of new neural networks to replace ones damaged due to events such as
stroke (Zhao, et al., 2013). A 2005 study showed that KitL protected rat cortical neurons
from both apoptotic and excitotoxic cell death in a PI3K/Akt-dependent mechanism
likely influencing NFĸB activity (Dhandapani, et al., 2005). This is interesting, as
unpublished data from our laboratory shows knock down of Pgrmc1 in hypothalamic
cells increases NFĸB synthesis (Adams and Petersen, unpublished).
1.4 Implications of sex hormone signaling in the hippocampus
Electrophysiological changes in the female hippocampus as a result of hormone
cycles have been investigated as early as 1968 (Terasawa and Timiras 1968), when it was
seen that synaptic changes occurred in association with difference phases of the estrous
cycle. E2 and P4 can also drastically change the number of dendritic spines on CA1
pyramidal neurons in rats (Woolley 1998). In ovariectomized female rats, cell
proliferation in the dentate gyrus is significantly decreased; however, E2 injections rescue
3

this phenotype (Tanapat, et al., 1999). The physiological relevance of these studies can be
seen in research showing that P4 injections in old mice improve their memory and
learning skills (Frye, 2008). P4 upregulates genes that promote mitosis in neural
progenitor cells (NPCs) of the dentate gyrus (Liu, et al. 2009). These cells do not express
the classical progesterone receptor, but they do express Pgrmc1 and 2. This proliferation
is abrogated by the use of an Erk1/2 inhibitor and this is interesting because the Erk1/2
pathway is found downstream of c-Kit signaling (Lennartsson and Rönnstrand 2012). The
mechanisms behind these hormonal changes in synaptic plasticity and neurogenesis are
still not very well understood.
1.5 Functions of the hippocampus
As in most mammals, the rodent hippocampus is made up of four different areas,
the CA1, CA2, CA3, and dentate gyrus. The subregions CA1, CA2 and CA3 are
primarily made up of pyramidal neuronal cells, while the dentate gyrus is made up of
granule cells. These granule cells project solely to cells residing in the CA3 section of the
hippocampus (Witter and Amaral 1995). Generally, both the CA1 and CA3 function in
episodic memory encoding, as lesions in these areas cause mice to perform significantly
worse in memory performance tests (Farovik, 2010). Recently, published work shows
that the CA2 is functionally important to social memory in mice. Social memory is the
ability to recognize familiar mice or littermates. When mice deficient in CA2 activity are
exposed to the same mouse continually at one hour intervals, they explore the other
mouse as if it was novel every time (Hitti, 2014). The dentate gyrus is involved in
sensory experiences as well as memory sequencing and pattern separation. An area of the
dentate gyrus known as the subgranular zone is one of only two areas in the brain where
4

adult neurogenesis occurs, the other being the subventricular zone (Drew, 2013). As both
Pgrmc1 and KitL mRNA are detected in the hippocampal formation, they may be
involved in mediating neurogenesis in this area.
1.6 Shared pathways of Pgrmc1 and Kit Ligand signaling
The same bioinformatics study of the Pgrmc1-dependent transcriptome in neural
cells that identified KitL as a target of Pgrmc1 showed Jak/Stat signaling to be a key
downstream pathway regulated by Pgrmc1 (Intlekoffer et al, unpublished). KitL has also
been connected to regulation of the Jak/Stat pathway, interacting with and
phosphorylating both Jak2 and Stat1 (Deberry, 1997) and phosphorylating Stat3 (Gotoh,
1996). Jak/Stat signaling contributes to cell viability, resulting in either cell death or
protection (Planas, et al., 2006) and it is predominantly activated through phosphorylation
cascades, allowing for rapid effects. Modulation of the Jak/Stat pathway in the form of
post-translational inhibition allows for Jak/Stat responses to be controlled and transient.
Cytokine activation of the Jak/Stat pathway may play an important role in the brain’s
immune response following an ischemic event. Stat1 and Stat3 are both activated in
neurons after being subjected to ischemia and Stat1 knockout mice are more resistant to
ischaemic brain injury (Planas, et al. 2006). The Jak/Stat pathway is a modulator of longterm potentiation (LTP) in the hippocampus (Nicolas, et al. 2012). LTP is an activity in
the brain that causes for strengthening of synapses and is heavily tied to learning.
Importantly, knock down or inhibition of Jak2 can impair induction of the LTP. This
may have clinical relevance as studies of Alzheimer’s disease pathology also show that
inactivation of Jak2/Stat3 phosphorylation can lead to memory loss and a deficit in
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working spatial memory (Chiba, et al., 2009). It remains to be determined if Pgrmc1 and
Kit Ligand are involved in the same mechanisms regulating Jak/Stat signaling.
Commonalities between Kit Ligand and Pgrmc1 have also been seen in regards to
aromatase (Cyp19). KitL has been shown to upregulate aromatase mRNA and protein
levels (Jin, et al. 2005), and Pgrmc1 is also involved in regulation and activation of
aromatase (Petersen, 2013). Aromatase has very important neuroendocrine functions in
the brain and its main responsibility is the metabolism of testosterone to estradiol.
Aromatase has been found to be neuroprotective as well. In mice, its expression is
induced following stroke and mice with a conditional aromatase knock out have more
damage following stroke than wild type counterparts (Roselli 2007).
1.7 Rationale and Objectives
Altered neurogenesis is an early critical event in the Alzheimer’s Disease (AD)
process and the hippocampus is specifically vulnerable to this phenomenon as the
subgranular zone is one of the only places adult neurogenesis occurs. A suggested
strategy in combating and possibly slowing AD is to preserve this neurogenesis (Mu &
Gage, 2011). Thus, understanding mechanisms in the hippocampus that regulate
neurogenesis and neuroprotection is important to better understanding neurodegenerative
disease. In view of evidence that Pgrmc1 may play a role in these functions, identifying
the underlying mechanisms may lead to new treatments for AD and other
neurodegenerative diseases.
Based on the information presented above, the hypothesis tested in these studies
is: Pgrmc1 regulates neural targets through KitL/c-Kit signaling in a P4-dependent
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and/or -independent manner. I tested this hypothesis by performing both in vitro and
in vivo studies. I first used in situ hybridization to map KitL and cKit mRNA in the
female rat brain to determine whether the pattern of distribution was similar to that of
Pgrmc1 mRNA, a condition that must be met if my hypothesis is correct. I next
performed in vitro studies in the immortalized mouse hippocampal cell line mHe-18.
These cells contain Pgrmc1, KitL and c-Kit, but do not have detectable levels of either
progesterone receptor (Pgr) mRNA or protein, making them suitable models to study
non-classical P4 signaling in the hippocampus. MHe-18 cells were treated with Pgrmc1
siRNA to test whether Pgrmc1 alters KitL or c-Kit expression. I next treated these cells
with Kit Ligand recombinant protein to study downstream regulation of c-Kit signaling in
the absence of Pgrmc1. Finally, the cells were treated in combination with Pgrmc1
siRNA and a c-Kit inhibitor AG-1296 to test if Pgrmc1 regulation of downstream targets
depended on c-Kit signaling.
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CHAPTER 2
MATERIALS AND METHODS
2.1 Study 1: Localization of c-Kit receptor and Kit Ligand in vivo
Before investigating a possible relationship between Pgrmc2 and KitL/c-Kit
signaling, I mapped the distribution of these genes throughout the brain and compared
the distribution to that of to Pgrmc1. Mapping studies of both Kit Ligand and c-Kit were
performed using S35-labeled cRNA probes and assessed using radiographic films and
emulsion autoradiography. The localization pattern of both ligand and receptor were then
compared to a previous Pgrmc1 mapping study (Petersen, et al. 2013) to find areas of
shared localization.
2.1.1 Tissue Collection
Brains of female Sprague-Dawley adult (n=3, approximately 60 days of age) and
neonatal pups (n=3, post-natal day 2) were previously collected and stored at -80°C.
Using a microtome (Leica CM3000, Nussloch, Germany), all six brains were
cryosectioned and 14-µm coronal forebrain sections were thaw-mounted onto gelatin
coated slides and stored at -80°C until use.
2.1.2 Complimentary RNA (cRNA) Probe Preparation
Primer sets with an amplicon of approximately 600 base pairs were designed for
both Kit Ligand and c-Kit, this was done using the National Center for Biotechnology
Information (NCBI) online nucleotide database in conjunction with Primer-Blast (NCBI).
Forward and reverse primers (Integrated DNA Technologies, Coralville, IA) can be
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found in Table 2. Using cDNA from an AVPV microdissected punch sample, a PCR
reaction was run using GoTaq® DNA Polymerase (Promega) according to
manufacturer’s instructions on a Mastercycler® Gradient Thermal Cycler (Eppendorf) for
1 cycle of 95°C for 2 minutes, followed by 39 cycles of 95°C for 1 minute, 56°C for 1
minute, and 72°C for 1 minute with a final 72°C extension cycle of 5 minutes.
Confirmation of amplification of sequences was done by running PCR products on a 1%
agarose gel with ethidium bromide in TAE buffer. Cloning of sequences and bacterial
transformation were done using the TOPO® TA Cloning® Kit (Invitrogen) according to
manufacturer’s instructions. Sequences were cloned into the pCR™II-TOPO® Vector
(Invitrogen) and transformed using One Shot® TOP10 chemically competent E. coli cells
(Invitrogen). Cells were plated on LB agar (Sigma-Aldrich) plates spread with X-Gal
(VWR) to screen for incorporation of plasmids, plates were incubated overnight at 37°C.
White colonies were then lysed and presence of plasmid was confirmed via PCR. One
white colony per plasmid was used to inoculate LB broth with 100µg/mL Ampicillin
(VWR) and incubated for 16 hours at 37°C on shaker. Plasmids were then isolated from
bacterial cultures using QIAGEN Plasmid Midi Kit (Qiagen) according to manufacturer’s
instructions. Concentration and purity of sample was then measured using the Nanodrop
8000 (Thermo Scientific) and plasmids were sequenced to confirm identity of sequence.
Plasmids were linearized by restriction digest and the enzymes HindIII (New England
Biolabs, Ipswich, MA) and EcoRV (Fisher) were used at a concentration of 5U of
enzyme per microgram of DNA. Efficacy of digest was confirmed by running digest
product and uncut product (control) on 1% Agarose gel. Digest was cleaned up by means
of a phenol/chloroform extraction. In vitro transcription of cRNA probes (both sense and
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anti-sense for KitL and c-Kit) was done in the presence of S35-labelled UTP (Perkin
Elmer, Shelton, CT) followed by a phenol chloroform extraction and ethanol
precipitation.
2.1.3 Prehybridization of Tissue
Prehybridization was done using all RNAse-free solutions prepared with H2O
treated with diethylpyrocarbate (DEPC H2O) (Fisher). Tissue slides were removed from 80°C freezer and allowed to thaw for no more than 10 minutes. Slides were loaded into
slide racks and washed in phosphate buffered saline/4% formalin (Fisher) (15 minutes),
2X SSC (1X SSC = 0.15 M NaCl/0.015 M sodium citrate, pH 7.0; 2 minutes),
triethanolamine HCL (VWR) with 0.25% acetic anhydride (Sigma) (10 minutes) all on a
platform shaker. This was followed by a brief 2X SSC rinse and then an ethanol
dehydration using 70%, 80%, 95%, and 100% ethanol in DEPC H2O. Then a 5-minute
chloroform wash was done before the final 100% and 95% ethanol washes, slides were
then allowed to air dry.
2.1.4 Hybridization of Tissue
Localization was carried out using S35-labeled antisense cRNA probes and the
sense cRNA probes were used as negative controls. Twenty µL of hybridization buffer
composed of 50% formamide (Fisher), 10% dextran sulfate (Sigma), 1X Denhardt’s
solution (Thermo Fisher Scientific), 2X SSC, 500µg/mL heparin sodium salt (Sigma),
035mg/mL yeast tRNA (Fisher), 0.1% sodium pyrophosphate (Sigma), and freshly added
0.4M dithiothreitol (Fisher) containing 1 X 106 cpm S35 was applied to each section.
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Slides were then covered with glass cover slips and placed in humidified large square
Nunc petri dishes and incubated 16-18 hours at 55°C.
2.1.5 Post-Hybridization of Tissue
Slides were removed from incubation and allowed to come to room temperature.
All washes/rinses were performed on an orbital shaker unless stated otherwise. Cover
slips were removed in a 1X SSC soak and slides were washed twice in 1X SSC at room
temp (15 minutes each), then washed in 50% formamide in 2X SSC for 20 minutes in a
52°C water bath and then rinsed twice in 2X SSC at room temperature (10 minutes each).
Slides were then incubated in RNase buffer (0.5 M NaCl, 10mM Tris pH 8.0, 1mM
EDTA pH 8.0) with 25µg/mL of RNase A (Fisher) in a 37°C water bath (30 minutes)
followed by a 10 minute 2X SSC rinse at room temperature. Slides are then incubated in
a 52°C water bath in 50% formamide in 2X SSC (10 minutes), then washed at room temp
in 2X SSC (10 minutes), followed by a brief deionized H2O rinse. Slides are then
dehydrated first in 70% ethanol, then 80% ethanol, followed by 95% ethanol and left to
air dry.
2.1.6 Detection
Once dry, slides were placed in autoradiography cassettes (8x10in, FisherBiotech)
against an 8x10inch sheet of KODAK® BioMax® Maximum Resolution (MR)
Autoradiography Film (Carestream Health, VWR) and film was then developed within
10-14 days. Subsequently, slides were analyzed using emulsion autoradiography. NTB
emulsion (VWR, Pennsylvania) was warmed in a 42°C water bath and diluted 1:1 with
ddH2O. Slides were then dipped in diluted emulsion in a dark room and left to dry on
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aluminum foil for 1-2 hours. Slides were then placed in light-tight boxes (covers off) with
desiccant tablets up against the side of a metal container with tissue sections parallel to
the ground and emulsion side up. These were left to dry in the dark room overnight. The
following day, covers were added to light-tight boxes and they were taped with electrical
tape and placed inside the metal box with slides perpendicular to the ground. Metal boxes
were then placed in a 4°C refrigerator free of radiation sources. Slides were developed
10-14 days later in the dark room using Kodak Dektol developer at 15°C (Fisher) using a
1:1 dilution prepared according to manufacturer’s instructions then fixed in and Kodak
fixer (Fisher) for 5 min. Slides were loaded into slide racks and placed in developer for 2
minutes, water for 30 seconds, and finally fixer for 5 minutes. Slides were dried and then
stained in filtered Toluidine blue for 5 minutes, allowed to dry, and cover-slipped.
Localization was determined using reference atlases such as the Allen Mouse Brain
Reference Atlas (Allen Institute for Brain Science, 2017) and Brain Maps: Structure of
the Rat Brain (Swanson, 1998). Atlases were used in conjunction light microscopic
analysis of toluidine blue stained tissue sections corresponding to the film
autoradiographic images.
2.2 Study 2: Pgrmc1 regulation of Kit Ligand mRNA in vitro and in vivo
To determine whether Pgrmc1 levels affect KitL and c-Kit synthesis in vitro, Pgrmc1
knockdown in a mouse embryonic hippocampal (mHe-18) cell line was verified via
qPCR. Kit Ligand and c-Kit mRNA levels were then measured in these cells with
Pgrmc1 knock down. To determine whether Pgrmc1 levels affect KitL and c-Kit
synthesis in vivo, Pgrmc1 and 2 double-conditional knockdown adult mice brains were
analyzed via qPCR.
12

2.2.1 SiRNA Transfection
I seeded mHe-18 cells at a density of 1.2 x 105 cells/mL in a 24-well plate in
DMEM supplemented with 5% FBS and 1% PSG. They were then immediately
transfected with Mm_Pgrmc1_1 Flexitube siRNA or AllStars Negative Control siRNA
(Qiagen, Valencia, CA) to a final concentration of 20nM with HiPerfect Transfection
Reagent (Qiagen) according to the manufacturer’s protocol. Cells were incubated at 37°C
in 5% CO2 for 48 hours and then harvested in Trizol and stored at -80°C until RNA
isolation.
2.2.2 Tissue Collection
Brains were collected from Pgrmc1 and Pgrmc2 dcKO and control female mouse
heads received from the James Pru laboratory (Washington State University, Pullman
WA). Brains were cryosectioned coronally using a microtome (Leica CM3000, Nussloch,
Germany) until the hippocampus was reached. A 150µm section was then taken and the
entire hippocampus (CA1, CA2, CA3, and the dentate gyrus) was removed using a
scalpel. Frozen tissue was transferred to a 1.5mL microcentrifuge tube on dry ice.
2.2.3 RNA isolation, reverse transcription, and quantitative polymerase chain
reaction (qPCR)
Cellular RNA was isolated using Trizol (Invitrogen, Carlsbad, California)
according to manufacturer’s instructions and reverse transcription was completed using
the M-MLV Reverse Transcription Kit (Promega, Madison, WI). Following reverse
transcription, cDNA was diluted 1:10 in nuclease-free water.
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RNA from tissue was isolated using Trizol and the Qiagen RNeasy Lipid Kit (Qiagen)
according to the manufacturer’s instructions. Reverse transcription was then completed
using the Quantitect Reverse Transcription kit (Qiagen) according to the manufacturer’s
protocol and cDNA was diluted 1:10 in nuclease free water.
For qPCR, the 1:10 dilution was combined with FastStart Universal SYBR Green
(ROX) mix (Roche Applied Science, Indianapolis, IN) with the correct primer. See
Table 1 for Kit Ligand, c-Kit receptor, Pgrmc1, and Gapdh forward and reverse primer
(Integrated DNA Technologies, Coralville, IA) sequences. The qPCR reactions were
accomplished using the Stratagene MX3005P Thermocycler (Agilent Technologies,
Wilmington, DE) with the settings: 95°C for 10 minutes followed by 40 cycles of 95°C
for 15 seconds, 60°C for 30 seconds, and 72°C for 30 seconds. MxPro™ qPCR analysis
software (Agilent Technologies) was used to obtain threshold cycle (Ct) values which
were then used to analyze various treatment effects on target genes using the delta delta
Ct method of analysis (Livak & Schmittgen, 2001). Normalization of target genes was
done using the housekeeping gene Gapdh. Results of each gene were then analyzed
statistically using GraphPad Prism Software (GraphPad Software, Inc., San Diego, CA)
using student two-tailed t-tests.
2.3 Study 3: Regulation of Kit Ligand as a sex hormone independent mechanism
To determine whether Pgrmc1regulation of KitL or c-Kit mRNA levels is affected
by ovarian sex hormones, mHe-18 cells were treated with 10nM estradiol (E2) and 10nM
P4. Pgrmc1, KitL, and c-Kit mRNA levels were then assessed using qPCR as in Study 1.

14

2.3.1 E2 and P4 Treatments
The mHe-18 cells were plated in Dulbecco’s Modification of Eagle’s Medium
(DMEM; Thermo Fisher Scientific, Rockford, IL) supplemented with 5% fetal bovine
serum (FBS; Thermo Fisher) and 1% penicillin streptomycin glutamine (PSG; Thermo
Fisher). When cell density reached approximately 65% confluency, media was changed
to DMEM with no phenol red (Thermo Fish Scientific) containing 5% charcoal-stripped
FBS (Atlanta Biologicals) and 1% PSG. Twenty-four hours later cells were treated with
10nM P4, 10nM E2, both 10nM P4 and 10nM E2, or vehicle control. Cells were then
harvested in Trizol 24 hours later and stored at -80°C until RNA isolation.
2.4 Study 4: Shared downstream targets of Kit Ligand/c-Kit and Pgrmc1 regulation
To determine if Kit Ligand/c-Kit signaling shared downstream targets, mHe-18
cells were treated with soluble Kit Ligand and then RNA was isolated and reverse
transcribed. Validation of KitL treatment effect was done by analyzing Bcl2 expression
levels using qPCR. Bcl2 is a known c-Kit signaling target and has been used previously
for validating treatments (Carson, et al., 1994; Dhandapani, et al., 2005). The cDNA
from this treatment was analyzed using a JAK/STAT RT2 Profiler PCR Array. This array
had been used previously in our laboratory to identify targets affected by Pgrmc1
knockdown, allowing for comparison of regulated targets between the two different
treatments. Targets taken from the qPCR array were then validated individually. See
Table 1 for Bcl2 and Pias1, 2,3 and 4 forward and reverse primer (Integrated DNA
Technologies) sequences.

15

2.4.1 Soluble Kit Ligand Treatments
The mHe-18 cells were plated in DMEM supplemented with 5% FBS and 1%
PSG. When cell density reached approximately 65% confluency, cells were treated with
1ng/mL, 10ng/mL, and 50ng/mL Recombinant Murine SCF (PeproTech, Rocky Hill, NJ)
or vehicle control. Cells were then harvested in Trizol 24 hours later and stored at -80°C
until RNA isolation.
2.4.2 PCR Array
The mouse JAK/STAT RT2 Profiler PCR Array (Qiagen) was used in conjunction
with cDNA from soluble Kit Ligand treated mHe-18 cells to identify Kit Ligand/c-Kit
signaling targets that are linked to the Jak/Stat pathway. cDNA was mixed with RT2
SYBR Green Mastermix (Qiagen) according to the JAK/STAT RT2 Profiler PCR Array
protocol and loaded onto the array plate for qPCR analysis. The cycling conditions used
were : 95°C for 10 minutes followed by 40 cycles of 95°C for 15 seconds and 60°C for 1
minute. Ct values were then analyzed using SABioscicences Web-based PCR Array Data
Analysis accessed on the Qiagen website.
2.5 Study 5: Effects of c-Kit signaling and Pgrmc1 on the synthesis of Pias1, 2, 3,
and 4
To determine whether Pgrmc1 mediates changes in the expression level of Pias
genes through KitL/c-Kit signaling, the known c-Kit inhibitor AG-1296 (Ueda, et al.,
2002; Letard, et al., 2008) was used in conjunction with siRNA experiments. Pias1, 2, 3,
and 4 expression levels were then assessed using qPCR as done in previous studies. Data
for each gene were analyzed using two-way ANOVA with multiple comparisons.
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2.5.1 SiRNA transfection and AG-1296 treatment
I seeded mHe-18 cells at a density of 1.5 x 105 cells/mL in a 24-well plate in
DMEM supplemented with 5% FBS and 1% PSG. They were then immediately
transfected with Mm_Pgrmc1_1 Flexitube siRNA or AllStars Negative Control siRNA to
a final concentration of 10nM with Lipofectamine® RNAiMax Transfection Reagent
(Invitrogen) according to the manufacturer’s protocol. Cells were incubated at 37°C in
5% CO2 for 24 hours and then media containing siRNA was replaced with DMEM
supplemented with 5% FBS, 1% PSG, and 10nM AG-1296 (Cayman Chemicals, Ann
Arbor, Michigan). Incubation continued for 24 hours and cells were then harvested in
Trizol and stored at -80°C until RNA isolation.
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Table 1. Primer pairs used in qPCR
5’ – 3’ Sequence

Gene

Forward GTGGAGTCATACTGGAACATGTAG
Mouse Gapdh
Reverse

AATGGTGAAGGTCGGTGTG

Forward

GCTGCAACAGGGGGTAACAT

Reverse

GAATCTCCGAAGAGGCCAGAA

Forward

GTGACGGTACATGGCTGCAT

Reverse

GGTGCACACCACCGTAAATG

Forward

CCTGCTCTACAAGATCGTTCGC

Reverse

GAACACCTTGCCGTTGATGG

Forward

AGAACTCTACAGGAGGCGGT

Reverse

GCTGTGGAATGGTGGATGGA

Forward

AATGGCGGATTTCGAGGAGT

Reverse

TATTCCGTCCAGCAAAGCCC

Forward

CTAGGGAAGATGCGCCTGAC

Reverse

AGCGACTCATAGGGAGCCTT

Forward

GCAGGAGGACCAATACCCAC

Reverse

GGCCTCTTAGGTTCCACACC

Mouse Kit Ligand

Mouse c-Kit

Mouse Pgrmc1

Mouse Pias1

Mouse Pias2

Mouse Pias3

Mouse Pias4

18

Table 2. Primer pairs used to make cRNA probes

5’ – 3’ Sequence

Gene
Forward

GCTCCAGAACAGCTAAACGG

Reverse

TGTTGAAGAGAGCACACAATCAC

Forward

GTCTCCACCATCCATCCAGC

Reverse

ACCGTAAATGTGTCCCCTTCC

Rat Kit Ligand

Rat c-Kit
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CHAPTER 3
RESULTS
3.1 Study 1
3.1.1 KitL and c-Kit mRNA is localized throughout the female rat brain
Both KitL and c-Kit mRNAs are present throughout the brain (Fig. 1 A1-13, B113) in adults. KitL has robust expression in the outer layers of the cortex (Co; A1-A12) as
well as in the anterodorsal preoptic nucleus (ADP; A3), the piriform cortex (PIR; A2), the
bed nucleus of the anterior commissure (BAC;A4), and the endopiriform nucleus (EP;
A5). It is expressed highly in many thalamic nuclei such as the triangular septal nucleus
(TS; A4), the paraventricular nucleus (PVA; A6), the anteroventral nucleus (AV; A6), the
centromedian nucleus (CM; A6), the reuniens thalamic nucleus (Re; A9), the medial
habenula (MH) and the lateral habenula (LH; A9), and the parafascicular nucleus (PF;
A11). It can also be seen in all areas of the hippocampal formation, most notably in the
dentate gyrus (DG;A10), as well as in the amygdalar region in the lateral amygdaloid
nucleus (LA;A11). Though c-Kit is found in some of the same areas as KitL, the
expression levels and patterns differ strikingly. C-Kit can be found more evenly
distributed throughout the cortical layers (B1-12), except the outer layer where it is
highest. Robust expression of c-Kit can also be seen in the MH and LH, as well as the
Subthalamic Nucleus (STN; B11). In the hippocampal formation, c-Kit is robustly
expressed throughout all tissues (B10).
Both KitL and c-Kit mRNAs are present throughout the brain (Fig. 2 A1-11, B111) in PND2 animals. KitL has robust expression in both the outer layer of the cortex, as
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well as the inner area (A2). It can also be seen in the PIR (A2), EP (A4), and the BAC
(A5). It is seen in a variety of thalamic nuclei such as the TS (A7), the PVA (A8), and the
AV (A8). It can also be seen in all areas of the hippocampal formation, most notably in
the DG (A9), as well as in the amygdalar region in the LA (A9).
The distribution patterns for c-Kit and KitL differed, with c-Kit showing a wider
distribution such that there was some overlap. In addition, expression levels differ. C-Kit
can be found more evenly distributed throughout the cortical layers (B1-12). Robust
expression of c-Kit can also be seen in the septohippocampal nucleus (SHi;B3), as well
as the subthalamic nucleus (STN; B9). In the hippocampal formation c-Kit is expressed
throughout all tissues (B10), though in the DG it is expressed in the outer layer of cells.
Further analysis using emulsion radiography on the adult brain sections shows both KitL
and c-Kit to be located in the pyramidal cell layer of the dentate gyrus (Fig. 3).
3.2 Study 2
3.2.1 Pgrmc1 silencing regulates KitL mRNA levels, but not c-Kit mRNA levels in
vitro and in vivo
Pgrmc1 siRNA treatments were first verified in mHe-18 cells and expression
levels of Pgrmc1, KitL, and c-Kit were measured using qPCR. Transfection with Pgrmc1
siRNA reduced Pgrmc1 levels when compared to scramble controls (Fig. 4A). Pgrmc1
knockdown significantly upregulated KitL mRNA when compared to scramble controls,
though it had no effect on c-kit gene expression (Fig. 4B). In the hippocampal tissue of
Pgrmc1/2 dcKO animals, KitL mRNA was significantly increased when compared to
controls and there was no effect on c-Kit mRNA levels (Fig. 4C).
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3.3 Study 3
3.3.1 Ovarian hormones regulate c-Kit and Pgrmc1 mRNA levels, but not KitL
mRNA levels
Treatment of mHe-18 cells with 10nM E2 significantly upregulated c-Kit mRNA
levels when compared to vehicle controls, but had no effect on KitL or Pgrmc1 mRNA
levels (Fig. 5A). Treatment with 10nM P4 significantly downregulated Pgrmc1 mRNA
levels when compared to vehicle controls, but had no effect on KitL or c-Kit mRNA
levels (Fig. 5B). E2 had no effect on P4 downregulation of Pgrmc1, but P4 completely
blocked upregulation of c-Kit by E2 (Fig. 4C).
3.4 Study 4
3.4.1 KitL/c-Kit signaling affects the expression level of genes associated with the
Jak/Stat pathway
The expression of bcl2, a known target of c-Kit signaling, was significantly
upregulated in the 10ng/mL and the 50ng/mL treatments (Fig. 6A). Levels of c-Kit
mRNA were also measured using qPCR (Fig.6B).
I then used cDNA from control mHe-18 cells and cells treated with 50ng/mL KitL
to perform the Mouse JAK/STAT Signaling Pathway RT2 Profiler PCR Array (Qiagen).
Table 3 shows preliminary data of the top five upregulated genes and the top five
downregulated genes. Unpublished data from our laboratory show Pgrmc1 knock down
also upregulates protein inhibitor of activated stat (Pias) family members. Therefore the
pias genes were picked for further analyses.
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3.4.2 KitL/c-Kit signaling mediates expression of Pias1, 2, and 3
Results of KitL treatment of mHe-18 cells are showin in Fig. 7A-C. Levels of Pias
2 mRNA were significantly upregulated when compared to vehicle controls in the
10ng/mL KitL treatment (Fig. 7B). Levels of Pias 3 mRNA were significantly
upregulated when compared to vehicle controls in the 50ng/mL KitL treatment (Fig. 7AC). Pias4 mRNA was not significantly upregulated in any of the three treatments (Fig.
7D). A biphasic response is seen in response to KitL treatment across Pias1, 2, and 3
(7A-C).
3.4.3 Pgrmc1 silencing upregulates Pias1-4 expression in vitro, but only affects Pias1
expression in vivo
Pgrmc1 silencing significantly upregulated Pias1, 2, 3, and 4 mRNA levels when
compared to the scramble controls (Fig. 8A). In the Pgrmc1/2 dcKO animals, Pias1
mRNA levels was upregulated, while Pias2-4 levels were not significantly affected (Fig.
8B).
3.5 Study 5
3.5.1 Pgrmc1 regulates the Pias family expression independently of KitL/c-Kit
signaling
To determine whether Pgrmc1 regulation of Pias1-4 mRNA expression is
mediated through c-Kit signaling, Pgrmc1 siRNA experiments were performed on mHe18 cells in the presence and absence of 10nM AG-1296 (Cayman Chemicals), a known cKit inhibitor. Pgrmc1, Pias1, Pias2, Pias3, and Pias4 mRNA levels were then measured
using qPCR. The Pgrmc1 knock down in the presence of siRNA were first validated.
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Pgrmc1 silencing significantly decreased Pgrmc1 expression levels in the presence of
vehicle, as well as in the presence of AG-1296 (Fig. 9A).
Neither Pgrmc1 nor AG-1296 had a significant effect on Pias1 mRNA levels after
any treatments (Fig. 9B). Pias2 and 3 mRNAs were increased by Pgrmc1 silencing in the
presence of vehicle (Fig. 9C,D), while Pias2 and 4 mRNA was increased by Pgrmc1
silencing in the presence of AG-1296 (Fig. 9C,E). Pias2 mRNA was decreased in the
presence of AG-1296 when compared to scramble/vehicle controls (Fig.9C), but it did
not significantly affect levels of Pias1, 2, and 4. Silencing in the presence of vehicle did
not significantly upregulate Pias4 mRNA levels, nor did silencing in the presence of AG1296 increase Pias3 levels.
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Figure 1. Hippocampal localization of KitL and c-Kit in adult rat brain using S35labeled cRNA probes
(A) KitL localization in the female adult rat brain using (A2-11) anti-sense and (A1, A12)
sense probes. (A13) Enlarged image of the hippocampal formation from A10. (B) c-Kit
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localization in the female adult rat brain using (B2-11) anti-sense and (B1, B12) sense
probes. Darkened areas denote radio-labeled probe binding and presence of specified
mRNA by anti-sense. Sense probes signify background signal. (B13) Enlarged image of
the hippocampal formation from B10. (ADP: anterodorsal preoptic nucleus; AR: arcuate
hypothalamic nucleus; AV: anteroventral thalamic nucleus; BAC: bed nucleus of the
anterior commissure; CA1: Cornu Ammonis, Pyramidal Cell Layer 1; CA2: Cornu
Ammonis, Pyramidal Cell Layer 2; CA3: Cornu Ammonis, Pyramidal Cell Layer 3; CM:
centromedian nucleus; Co: cortical layers; CP: caudate putamen; DM: dorsomedial
hypothalamic nucleus; DG: dentate gyrus; EP: endopiriform nucleus; LA: lateral
amygdaloid nucleus; LH: lateral habenular nucleus; MH: medial habenular nucleus; PF:
parafascicular thalamic nucleus; PIR: piriform cortex; PVA: paraventricular nucleus; Re:
reuniens thalamic nucleus; STN: subthalamic nucleus; TS: triangular septal nucleus)
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Figure 2. Hippocampal localization of KitL and c-Kit in PND2 rat brain using S35labeled cRNA probes
(A) KitL localization in the female developing rat brain using (A2-9) anti-sense and (A1,
A10) sense probes. (A11) Enlarged image of the hippocampal formation from A9. (B) cKit localization in the female adult rat brain using (B2-9) anti-sense and (B1, B10) sense
probes. (B11) Enlarged image of the hippocampal formation from B9. Darkened areas
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denote radio-labeled probe binding and presence of specified mRNA by anti-sense.
Sense probes signify background signal. (ADP: anterodorsal preoptic nucleus; AV:
anteroventral thalamic nucleus; BAC: bed nucleus of the anterior commissure; CA1:
Cornu Ammonis, Pyramidal Cell Layer 1; CA2: Cornu Ammonis, Pyramidal Cell Layer
2; CA3: Cornu Ammonis, Pyramidal Cell Layer 3; Co: cortical layers; CP: caudate
putamen; DG: dentate gyrus; EP: endopiriform nucleus; LA: lateral amygdaloid nucleus;
PVA: paraventricular nucleus; SHi: septohippocampal nucleus; TS: triangular septal
nucleus)
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Kit Ligand

c-Kit Receptor

Figure 3 KitL and c-Kit mRNA signals are found in the adult cell layer of the
dentate gyrus
Shown are KitL and c-Kit localization in the dentate gyrus of the hippocampal formation.
Signal is indicated by silver grains, these depict S35-labeled anti-sense cRNA probe
binding. Black arrows indicate areas of silver grain signal. Toluidine blue staining allows
for visualization of cell nuclei.
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Figure 4. Pgrmc1 regulation of KitL synthesis in vitro and in vivo
(A) Validation of in vitro Pgrmc1 knockdown using siRNA in mHe-18 cells. (B) KitL
and c-Kit mRNA levels following 48 hour Pgrmc1 siRNA treatment on mHe-18 cell
lines. (C) KitL and c-Kit mRNA levels in micro dissected hippocampal tissue of control
and Pgrmc1/2 dcKO mice. (A-C) Genes were analyzed independently using a student ttest; Bars = means±SEM. *Significantly different from scramble or control; * = p < 0.05,
** = p < 0.01, *** = p < 0.001.
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Figure 5. Effects of ovarian hormones on KitL, c-Kit, and Pgrmc1 expression levels
(A) Effects of estradiol (10nM) on KitL, c-Kit, and Pgrmc1 mRNA expression levels in
mHe-18 cells. (B) Effects of progesterone (10nM) on KitL, c-Kit, and Pgrmc1 mRNA
expression levels in mHe-18 cells. (C) Effects of combined estradiol (10nM) and
progesterone (10nM) on KitL, c-Kit, and Pgrmc1 mRNA expression levels in mHe-18
cells. (A-C) Genes were analyzed independently using a student t-test; Bars =
means±SEM.. *Significantly different from vehicle control; * = p < 0.05, ** = p < 0.01,
*** = p < 0.001.
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Figure 6. Bcl2 and c-Kit mRNA levels in response to soluble KitL treatment
(A) Bcl2 and (B) c-Kit mRNA levels following soluble KitL dose concentrations of
1ng/mL, 10ng/mL, and 50ng/mL on mHe-18 cells. Gene was analyzed using a student ttest; Bars = means±SEM. *Significantly different from scramble or control; * = p < 0.05,
** = p < 0.01, *** = p < 0.001.
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Table 3. Genes found to be regulated by Pgrmc1 using JAK/STAT PCR Array
Gene

Abbreviation

Accession
Number

Fold
Change

Protein inhibitor of activated STAT 1

Pias1

NM_019663

3.0525

MAD homolog 1 (Drosophila)

Smad1

NM_008539

1.366

SFFV proviral integration 1

Sp1

NM_011355

1.1892

Interferon regulatory factor 9

Irf9

NM_008394

1.1567

MAD homolog 3 (Drosophila)

Smad3

NM_016769

1.0943

Tyrosine kinase 2

Tyk2

NM_018793

-1.2483

Suppressor of cytokine signaling 2

Socs3

NM_007706

-1.2058

MAD homolog 2 (Drosophila)

Smad2

NM_010754

-1.1567

Fas (TNF receptor superfamily
member 6)

Fas

NM_007987

-1.1487

YY1 transcription factor

Yy1

NM_009537

-1.1487
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Figure 7. Pias family mRNA levels in response to soluble KitL treatment
Effects of varying concentrations of soluble KitL on (A) Pias1 mRNA, (B) Pias2 mRNA,
(C) Pias3 mRNA, and (D) Pias4 mRNA levels in mHe-18 cells. (A-D) Genes were
analyzed independently using a student t-test; Bars = means±SEM. * = p < 0.05, ** = p <
0.01, *** = p < 0.001.
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Figure 8. Pgrmc1 regulation of Pias1, 2, 3, and 4 synthesis in vitro and in vivo
(A) Pias1-4 mRNA levels following 48 hour Pgrmc1 siRNA treatment on mHe-18 cell
lines. (B) Pias1-4 mRNA levels in micro dissected hippocampal tissue of control and
Pgrmc1/2 dcKO mice. (A-B) Genes were analyzed independently using a student t-test;
Bars = means±SEM. *Significantly different from scramble or control; * = p < 0.05, ** =
p < 0.01, *** = p < 0.001.
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Figure 9. Pgrmc1 regulation of Pias family synthesis independent of KitL/c-Kit
signaling
(A) Validation of in vitro Pgrmc1 knockdown using siRNA in mHe-18 cells. (B) Pias1,
(C) Pias2, (D) Pias3, and (E) Pias4 mRNA levels following 48 hour Pgrmc1 siRNA
treatment in the presence and absence of AG-1296 on mHe-18 cell lines. (A-D) Gene
values were analyzed using two-way ANOVA followed by multiple comparisons. Bars =
means±SEM. a Significantly different from Scramble/Vehicle. b Significantly different
from Pgrmc1 siRNA/Vehicle. c Significantly different from Scramble/AG-1296.
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CHAPTER 4
DISCUSSION
My in vitro and in vivo findings demonstrate a connection between Pgrmc1 and
KitL/c-Kit signaling in hippocampal neurons. First, KitL and c-Kit are localized to many
regions related to specific neural functions in which Pgrmc1 also localizes. Of particular
interest is the hippocampal formation where each of these molecules is expressed highly.
Second, Pgrmc1 knockdown upregulates KitL in vivo and in immortalized hippocampal
neurons. The protein inhibitor of activated stats (Pias) family members were identified as
downstream targets of KitL and Pgrmc1, implicating both Pgrmc1 and KitL in Jak/Stat
signaling. Consistent with the idea that Pgrmc1 represses KitL expression, Pgrmc1
suppresses, but KitL upregulates Pias 1, 2, and 3 mRNA levels. However, c-Kit
antagonists do not alter the effects of Pgrmc1 knockdown on pias gene expression.
Finally my results suggest the intriguing possibility that observed estradiol stimulation of
neurogenesis and progesterone reversal of this effect may be through c-Kit.
My findings show that although KitL and c-Kit are in many of the same regions,
the difference in expression levels is immediately obvious in both adult and PND2 brains.
A similarly divergent pattern has been described previously in embryos (Keshet, et al.,
1991). Differences between KitL and the c-Kit receptor localization may be explained by
the fact that the ligand can be secreted. Several lines of evidence suggest that secreted
KitL plays a role in neurogenesis. In the developing brain, KitL mRNA is detected in the
main areas of neurogenesis, such as the subventricular zone and the inner layers of the
cortex (McConnell, 1995). These mRNA distribution patterns were not seen in the adult
brains. This is expected as the rat brain continues developing until day 60 (Semple, et al.,
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2013) at which point it has a much lower level of neurogenesis. It is interesting to note
that the c-Kit pattern remains the same in developing and adult brains except in the
dentate gyrus. In the PND2 brain, c-Kit is localized to the outermost regions of the
dentate gyrus, while in the adult it is detected within the structure. Though it is
impossible without cellular markers to confirm what cell types c-Kit is in, a similar
pattern of ligand and receptor distribution are also seen in the developing cortex. In the
this region, KitL mRNA is detected in Purkinje cell bodies and c-Kit mRNA is detected
in the interneuron basket cells surrounding the Purkinje cells (Manova, et al., 1992). This
evidence builds a case supporting KitL and c-Kit involvement in synaptic organization.
Similarly, KitL and c-Kit signaling may affect the development of the dentate gyrus.
Bone morphogenic protein (Bmp) induces kitl expression (West, et al., 2010) (Otsuka &
Shimasaki, 2002) and silencing of bmp leads to a smaller dentate gyrus (Caronia, et al.,
2010). My in situ hybridization data adds to the notion that KitL/c-Kit signaling is
involved in specific neural functions such as neurogenesis and synaptogenesis.
My data supports the idea that pgrmc1, kitl and c-kit may interact, as their
expression patterns overlap throughout the forebrain in areas with specific functions such
as neurogenesis. Though it is widely established that the major area of the adult brain that
undergoes neurogenesis is the dentate gyrus, many of the nuclei in which KitL was
detected may also be sites of adult neurogenesis. Among these areas are the amygdala
(Fowler, et al., 2009), the arcuate (McNay, et al., 2012), the piriform cortex (Shapiro, et
al., 2007), and areas of the hypothalamus (Pierce & Xu, 2011). Pgrmc1 has also been
detected in all of these areas, as well as the dentate gyrus (Intlekofer and Petersen 2011).
The dentate gyrus does not contain the classical progesterone receptor, and it has been
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suggested that P4 effects of neurogenesis in this area are mediated by Pgrmc1 (Bali, et al.
2012). Pgrmc1 has been shown to be regulated by E2 and P4 in other brain nuclei as well
(Intlekofer & Petersen, 2011), supporting the idea that sex hormones may mediate some
of these mechanisms.
My in vitro findings are the first to show Pgrmc1 regulation of KitL synthesis.
Though there is a Pgrmc1 binding site on the KitL promoter (Peluso, personal
communication), more studies must be done to show if Pgrmc1 has a direct effect on
KitL synthesis. It is possible that Pgrmc1 affects the mRNA levels of other genes, which
in turn regulate KitL. The varying sub cellular localization of the Pgrmc1 protein allow
for abundant possibilities for its regulatory mechanisms. Recent x-ray crystallography
work has made the structure of the cytosolic domain of Pgrmc1 known (Kabe, et al.,
2016), providing further insight into its functions. For example, it is now known that
Pgrmc1 has a predicted SH2-domain target sequence (Cahill, et al., 2016). This sequence
would allow Pgrmc1 to interact and be phosphorylated by proteins with SH2 domains,
such as the c-Kit receptor. This may suggest a feedback loop involving phosphorylation
of Pgrmc1 by the c-Kit receptor.
My data are the first to link KitL/c-Kit signaling and Pgrmc1with the regulation
of the pias family expression levels. The Pias family is composed of four members
(Pias1, Pias2, Pias3, and Pias4) and they repress various STATs by binding to their DNA
binding domain (J. Palvimo 2007). The biphasic trend seen in the KitL dose response
may be explained by the down regulation of the receptor in response to ligand binding.
The down regulation can occur through decreased mRNA levels, intracellular
degradation, and inactivation of the kinase domain (J. &. Lennartsson 2012). A
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connection between Pgrmc1 and the Pias family is intriguing, as our laboratory has
shown that Pgrmc1 may be involved in regulating jak1 and jak2 (Adams and Petersen,
Unpublished). Though Pgrmc1 knock down upregulated all four members of the Pias
family, only Pias1 was upregulated in vivo. Pgrmc2 is silenced in the dcKO brain tissue
as well and it is unknown if this contributes to the conflicting data. The combination
treatment of Pgrmc1 siRNA and AG-1296 did not abrogate Pgrmc1 effects on the Pias1,
2, 3, or 4. This suggests that Pgrmc1 and KitL are mediating Pias expression levels
through independent mechanisms. Pias1 expression levels did not change in response to
siRNA treatment as they did in the previous study. An explanation for this may be that
mHe-18 cells used were at a later passage than previous cells and this may have affected
their expression profiles. Both Pias2 and Pias4 were significantly downregulated in the
presence of AG-1296. Unfortunately AG-1296 also inhibits platelet derived growth factor
(PDGF), so further studies need to be done to confirm that this down regulation is a direct
effect of c-Kit signaling and not a caveat of the inhibitor. Though the role of Pias family
members in hippocampal functions has not been thoroughly investigated, one group has
found Pias1 to be upregulated in “fast learners” compared to “slow learners” when
looking at hippocampal mRNA. Follow-up studies revealed that overexpression of Pias1
in rats enhanced their spatial learning abilities (Tai, et al., 2011). My data therefore
suggest a mechanism by which Pgrmc1 is involved in learning and memory through both
KitL and Pias1, 2, 3, and 4. Specifically, regulation of pias family expression levels by
Pgrmc1 and KitL may modify and control the transient responses seen from Jak/Stat
signaling.

40

The dramatic upregulation of c-Kit by E2 is consistent with previous evidence that
E2 may mediate neurogenesis. Although my findings are the first to show E2 effects on cKit in the brain, similar effects have been observed in the testes and prostate (Correia, et
al., 2014) (Figueira, et al., 2016). No previous work studied the P4 regulation of E2mediated c-Kit signaling, but other work shows that either E2 or P4 alone doubled the
number of proliferating neural progenitor cells (NPCs) in the dentate gyrus while
administration of simultaneous E2 and P4 has no effect (Bali, et al., 2012). Similarly, E2
increases dendritic spine number and density in hippocampal CA1 pyramidal cells, while
addition of P4 reverses the effect (Woolley & McEwen, 1993). The ability of P4 to
increase the proliferation of NPCs has also been attributed to Pgrmc1 (Liu, et al., 2009),
this finding contradicts my data as no change was seen in c-Kit following P4 treatment.
This does not rule out a connection between P4 and c-Kit signaling, as there may be nongenomic effects such as phosphorylation triggered by P4 through Pgrmc1. As c-Kit
signaling and estradiol have also already been implicated in neurogenesis, these data give
insight into possible cellular mechanisms behind it.
Knowledge of the KitL/cKit pathway can be applied to many clinical situations as
well. In 2010, Northwestern University filed a patent on an invention using KitL
polypeptide “alone and in combination with granulocyte colony stimulating factor (GCSF) polypeptide, in the prevention or treatment of injury to the brain after cerebral
ischemia or neurological disorder.” (Zhao, et al., 2013). In neurodegenerative diseases
such as Alzheimer’s disease (AD) and Parkinson’s, the hippocampus is very sensitive to
damage. Induced neurogenesis has been suggested as a viable treatment to prolong the
damages of AD (Mu and Gage 2011). Future directions for this work should include the
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investigation of KitL regulation of cell proliferation in hippocampal neurons to more
clearly establish this pathway in neurogenesis. Overall, my data builds a case for
regulation of hippocampal functions through KitL and Pgrmc1 and their downstream
neural targets such as Pias1, 2, 3, 4 and indicates that this mechanism may be influenced
by ovarian hormones. Based on the mapping data provided by my work, there are many
other potential areas to investigate regarding this pathway. The understanding of Pgrmc1
and KitL effects in the brain are still very new, leaving many exciting directions that can
be taken with these data.

Figure 10. Suggested pathway based on experimental findings.
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